Published in Vaccine Weekly, April 20th, 2005
The scientists received the award for the development of Prevnar, pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein), the first conjugate vaccine to help prevent invasive pneumococcal disease caused by Streptococcus pneumoniae in infants and children up to the age of 2. The scientists accepted the award at PhRMA's Annual Meeting in Washington, D.C.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly